OpenRegistry
Companies House/London/Company profile

NUCLEARMEDIX LIMITED

Active
16134861·incorporated 2024-12-13

NUCLEARMEDIX LIMITED is an active UK private limited company, incorporated on 13 December 2024 at Companies House (number 16134861; OpenRegistry canonical ID GB-16134861-nuclearmedix-limited). Sophymarine's OpenRegistry classifies it under SIC 72110 (Research and experimental development on biotechnology), one of 4,219 active UK entities in that code and one of 1,093,852 active companies registered in London (postcode W12). Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Status
Active
Type
Private Limited Company
Incorporated
2024-12-13
Registered Address
GN1 COMMONWEALTH BUILDING, HAMMERSMITH HOSPITAL, LONDON, W12 0NN, UNITED KINGDOM
SIC
72110 — Research and experimental development on biotechnology
Country of origin
United Kingdom

Accounts

Next accounts due 2026-09-13. Financial year-end: 31/03. Filing class: NO ACCOUNTS FILED.

Confirmation statement

Last confirmation statement made up to 2025-12-12. Next confirmation statement due 2026-12-26.

Persons with significant control

NUCLEARMEDIX LIMITED has 2 persons with significant control on file:

  • Professor Eric Ofori Aboagye born 1965 resident in England, British national. Notified 2024-12-13.
    • Owns 50–75% of shares
    • Holds 50–75% of voting rights
    • Has the right to appoint and remove directors
  • Dr Ruisi Fu born 1991 resident in England, Chinese national. Notified 2024-12-13.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
    • Has the right to appoint and remove directors

Similar UK companies

Other companies registered under SIC 72110 (Research and experimental development on biotechnology):

Other companies registered in London: